In addition, Bhlhe40 has been shown to be a key regulator of CD8+ TRM formation and function, as deletion of Bhlhe40 significantly reduces CD8+ TRM formation and attenuates the anti-tumor activity of CD8+ T cells [27]. The gene discussed is CD8A; the disease is neoplasm.